1,2,4-triazole has been researched along with quinoline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Park, SW; Patel, RV | 1 |
| Abdel-Aziz, M; Abdelhamid, D; Dalby, KN; Hassan, HA; Kaoud, TS; Mohassab, AM | 1 |
| Abdel-Aziz, M; Abdelhamid, D; Fujita, M; Gouda, AM; Hassan, HA; Mohassab, AM; Otsuka, M; Tateishi, H; Youssif, BGM | 1 |
3 other study(ies) available for 1,2,4-triazole and quinoline
| Article | Year |
|---|---|
Access to a new class of biologically active quinoline based 1,2,4-triazoles.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Quinolines; Structure-Activity Relationship; Triazoles | 2014 |
Novel quinoline incorporating 1,2,4-triazole/oxime hybrids: Synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations.
Topics: Animals; Anti-Inflammatory Agents; Binding Sites; Catalytic Domain; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Edema; Enzyme Activation; Gastric Mucosa; Inhibitory Concentration 50; Kinetics; Liver; Molecular Docking Simulation; Nitric Oxide; Oximes; Quinolines; Rats; Structure-Activity Relationship; Triazoles | 2017 |
Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAF
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Chalcone; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Molecular Structure; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Quinolines; Structure-Activity Relationship; Triazoles | 2021 |